SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 11,809,394
- Share change
- -56,769
- Total reported value
- $74,647,000
- Price per share
- $6.47
- Number of holders
- 16
- Value change
- -$363,749
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP P8696W104:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
|
Company |
8.2%
|
5,900,000
|
$38,173,000 | — | 31 Mar 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
4%
|
2,839,500
|
$18,372,000 | — | 31 Mar 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.3%
|
2,375,841
|
$15,372,000 | — | 31 Mar 2019 | |
| Neumann Advisory Hong Kong Ltd |
13F
|
Company |
0.44%
|
315,586
|
$2,042,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
160,875
|
$1,041,000 | — | 31 Mar 2019 | |
| Yorktown Management & Research Co Inc |
13F
|
Company |
0.1%
|
74,893
|
$485,000 | — | 31 Mar 2019 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.1%
|
68,732
|
$445,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,717
|
$179,000 | — | 31 Mar 2019 | |
| RAMSEY QUANTITATIVE SYSTEMS |
13F
|
Company |
0.03%
|
23,129
|
$150,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
22,374
|
$144,000 | — | 31 Mar 2019 | |
| Freedom Investment Management, Inc. |
13F
|
Company |
0.03%
|
20,851
|
$135,000 | — | 31 Mar 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
20,020
|
$130,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,557
|
$42,000 | — | 31 Mar 2019 | |
| Parallax Volatility Advisers, L.P. |
13F
|
Company |
0.01%
|
5,055
|
$33,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,400
|
$9,000 | — | 31 Mar 2019 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
1,362
|
$9,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,250
|
$8,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
424
|
$3,000 | — | 31 Mar 2019 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
412
|
$3,000 | — | 31 Mar 2019 | |
| Financial Gravity Asset Management, Inc. |
13F
|
Company |
0%
|
185
|
$1,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
94
|
$1,000 | — | 31 Mar 2019 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q2 2019
As of 30 Jun 2019,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,809,394 shares.
The largest 10 holders included
Vivo Capital, LLC, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Neumann Advisory Hong Kong Ltd, STATE STREET CORP, Yorktown Management & Research Co Inc, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, GEODE CAPITAL MANAGEMENT, LLC, Eqis Capital Management, Inc., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
20
Q2 2019 holders
16
Holder diff
-4
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.